Real-World Evidence & Diagnostic Scaling
Focus: Translating clinical trial data into real-world medicine, and how AI can bridge the gap between expensive PET scans and scalable blood tests.
1. "The LEADER Study Reality Check: Bridging the Gap Between Clinical Trials and Real-World EHR Data"
The Hook: The newly presented LEADER study (July 14, 2026) followed Alzheimer's patients on Leqembi in diverse, real-world clinical settings over 17 months, showing that 83% of patients remained stable or improved—matching clinical trial efficacy.
The Angle: Explore the massive difference between clean, hyper-curated clinical trial cohorts and "noisy" real-world patients (who often have multiple co-morbidities, varying demographics, and inconsistent dosing schedules). Explain how Glassbury AI uses natural language processing (NLP) and electronic health record (EHR) parsing to track real-world drug efficacy and safety outside of sterile trial environments.
Why It Matters Now: Real-world evidence (RWE) is the gold standard for clinical adoption right now. Showing how Glassbury processes messy EHR data to prove real-world outcomes builds immense clinical credibility.
2. "Predicting 10 Years of Decline: The Engineering Behind Scalable Blood-Based Biomarkers"
The Hook: New 10-year longitudinal data presented at AAIC 2026 demonstrates that blood-based p-tau217 measurements can highly accurately predict cognitive decline a decade in advance, matching expensive, invasive PET scans.
The Angle: Explain the computational bottleneck of scaling blood-based biomarkers. How can machine learning models control for secondary factors (like kidney function, metabolic disease, or systemic inflammation) that naturally alter p-tau levels in blood? Discuss how Glassbury's multi-modal AI corrects these biological "noise" factors to make blood tests universally reliable across diverse patient populations.
Why It Matters Now: Diagnostics are rapidly moving from the imaging center to the primary care clinic. Explaining the software required to make blood tests reliable positions Glassbury as a vital piece of the diagnostic puzzle.
